Long Term Extension Trial of Setmelanotide
Public ClinicalTrials.gov record NCT03651765. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Study identification
- NCT ID
- NCT03651765
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Rhythm Pharmaceuticals, Inc.
- Industry
- Enrollment
- 205 participants
Conditions and interventions
Interventions
- Setmelanotide Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 14, 2018
- Primary completion
- Jan 8, 2025
- Completion
- Jan 8, 2025
- Last update posted
- May 30, 2025
2018 – 2025
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Synexus Clinical Research US, Inc. - Phoenix Southeast | Chandler | Arizona | 85224 | — |
| Honor Health Research Institute | Scottsdale | Arizona | 85258 | — |
| San Diego Wake Research | San Diego | California | 92108 | — |
| University of Florida College of Medicine | Gainesville | Florida | 32610 | — |
| Baystate Medical Center | Springfield | Massachusetts | 01107 | — |
| University at Buffalo | Buffalo | New York | 14203 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Wake Research | Raleigh | North Carolina | 27612 | — |
| Obesity Institute, Geisinger Clinic | Danville | Pennsylvania | 17822-2607 | — |
| Childrens Hospital of Philadephia | Philadelphia | Pennsylvania | 19104 | — |
| Synexus Clinical Research US, Inc.- Primary Care Associates, PC | Anderson | South Carolina | 29621 | — |
| Wake Research TN | Chattanooga | Tennessee | 37421 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | — |
| Seattle Children's Research Institute | Seattle | Washington | 98101 | — |
| Marshfield Clinic Research Institute | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03651765, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2025 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03651765 live on ClinicalTrials.gov.